Search
for
Sort by
Research 361–390 of 1000+
- Assessing the safety of topical minoxidil through disproportionality analysis of FAERS reports
- Implementing patient safety and quality improvement in dermatology. Part 1: Patient safety science
- The efficacy of topical prostaglandin analogs for hair loss: A systematic review and meta-analysis
- Comparative efficacy and safety of platelet-rich plasma (PRP), injectable platelet-rich fibrin (i-PRF) and concentrated growth factors (CGF) for female pattern hair loss (FPHL): a prospective multicenter randomized clinical trial
- Meta-Analysis of the Efficacy of Platelet-Rich Plasma in Treating Skin Aging
- Investigator‐blinded, controlled, and randomized comparative study on 1565 nm non‐ablative fractional laser versus 5% minoxidil for treatment of androgenetic alopecia
- Long-term (10-year) efficacy of finasteride in 523 Japanese men with androgenetic alopecia
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen: A Phase III Research Study of Female Sexual Dysfunction in Women on Testosterone Patch Without Estrogen (APHRODITE)
- Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
- Regulatory, Ethical, and Safety Considerations of Exosome‐Based Therapies in Dermatology
- Patient‐reported outcomes of topical finasteride/minoxidil treatment for male androgenetic alopecia: A retrospective study using telemedical data
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- How routine pharmacovigilance failed to identify finasteride’s persistent sexual side effects
- Alopecia With Endocrine Therapies in Patients With Cancer
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Epidemiological Trends in Alopecia Areata at the Global, Regional, and National Levels
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- INDIVIDUAL ARTICLE: USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
- Cellular therapeutics and immunotherapies in wound healing – on the pulse of time?
- Effects of 5-alpha reductase inhibitors
- Antihelminthic Drugs
- Drug eruptions in dermatology
- Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study
- Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management
- Post-finasteride syndrome: An emerging clinical problem
- Comparison of Different Alpha-blocker Combinations in Male Hypertensives with Refractory Lower Urinary Tract Symptoms
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Nutrition and the deleterious side effects of nutritional supplements
- Harmless Herbs? A Review of the Recent Literature